[1]
S. Aglawe, “Development and Evaluation of Surface-Functionalized Rifampicin Nanoparticles for Targeted Pulmonary Drug Delivery in Tuberculosis Therapy ”, injoere, vol. 6, no. S5, pp. 593–602, Jul. 2026, doi: 10.70102/agcv2026.